Goldman Sachs Downgrades Envision Healthcare Holdings To Buy

Analysts at Goldman Sachs downgraded

from Conviction Buy to Buy. The price target for Envision Healthcare Holdings is set to $43. Envision Healthcare Holdings shares have gained 5.43 percent over the past 52 weeks, while the S&P 500 index has surged 7.51 percent in the same period. Envision Healthcare Holdings' shares fell 0.08 percent to close at $37.25 yesterday.